We are live on ! Find out more
RCM

Radcliffe Capital Management Portfolio holdings

AUM $1.33B
1-Year Est. Return 1.18%
This Fund
S&P 500
This Quarter Est. Return
-9.24%
1 Year Est. Return
+1.18%
3 Year Est. Return
+4.94%
5 Year Est. Return
-24.37%
10 Year Est. Return
-27.33%
AUM
$4.4B
AUM Growth
+$581M
Cap. Flow
-$25.7M
Cap. Flow %
-0.58%
Top 10 Hldgs %
14.78%
Holding
1,342
New
290
Increased
298
Reduced
33
Closed
125
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
GCTS.WS
651
GCT Semiconductor Holding Warrants
GCTS.WS
$20.9M
$1.99M 0.05%
200,000
GAPA
652
DELISTED
G&P Acquisition Corp.
GAPA
$1.99M 0.05%
200,000
MOBX icon
653
Mobix Labs
MOBX
$26M
$1.98M 0.05%
20,000
PET
654
DELISTED
Wag!
PET
$1.98M 0.05%
200,000
DHAIW
655
DELISTED
DIH Holding US Inc Warrants
DHAIW
$1.98M 0.05%
+201,031
New +$15.9K
EVE.WS
656
DELISTED
EVe Mobility Acquisition Corp Redeemable warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50
EVE.WS
$1.98M 0.05%
+200,000
New +$57.9K
BFAC.WS
657
DELISTED
Battery Future Acquisition Corp. Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 per share
BFAC.WS
$1.98M 0.05%
+200,000
New +$61.2K
IMPX.WS
658
DELISTED
AEA-Bridges Impact Corp Warrants
IMPX.WS
$1.98M 0.05%
200,000
CLDI.WS
659
DELISTED
Calidi Biotherapeutics, Inc. Redeemable Warrants, each whole warrant exercisable for 1/10th of a share of Common Stock at an exercise price of $115.00
CLDI.WS
$1.98M 0.05%
199,999
BIOSW
660
DELISTED
BioPlus Acquisition Corp. Warrants
BIOSW
$1.98M 0.04%
+200,049
New +$52K
BLTSW
661
DELISTED
Bright Lights Acquisition Corp. Warrant
BLTSW
$1.97M 0.04%
200,000
AVAN.WS
662
DELISTED
Avanti Acquisition Corp. Redeemable Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50
AVAN.WS
$1.97M 0.04%
200,000
PGRWW
663
DELISTED
Progress Acquisition Corp. Warrant
PGRWW
$1.97M 0.04%
200,000
EPHYW
664
DELISTED
Epiphany Technology Acquisition Corp. Warrant
EPHYW
$1.96M 0.04%
199,999
SEPAW
665
DELISTED
SEP Acquisition Corp Warrants
SEPAW
$1.96M 0.04%
199,999
IMAQW
666
DELISTED
International Media Acquisition Corp. Warrants
IMAQW
$1.96M 0.04%
198,000
IMAQ
667
DELISTED
International Media Acquisition Corp. Class A Common Stock
IMAQ
$1.96M 0.04%
198,000
KAIRW
668
DELISTED
Kairos Acquisition Corp. Warrant
KAIRW
$1.96M 0.04%
200,000
BNZIW
669
DELISTED
Banzai International Warrant
BNZIW
$1.96M 0.04%
200,000
BNAIW
670
Brand Engagement Network Warrant
BNAIW
$2.16M
$1.96M 0.04%
199,999
SHQAW
671
DELISTED
Shelter Acquisition Corporation I Warrants
SHQAW
$1.96M 0.04%
200,000
ARYE
672
DELISTED
ARYA Sciences Acquisition Corp V Class A Ordinary Shares
ARYE
$1.96M 0.04%
201,374
+1,374
+0.7% +$13.3K
TWLVW
673
DELISTED
Twelve Seas Investment Company II Warrant
TWLVW
$1.95M 0.04%
199,998
ACAH
674
DELISTED
Atlantic Coastal Acquisition Corp. Class A Common Stock
ACAH
$1.95M 0.04%
200,083
+1
+0% +$10
OHAAW
675
DELISTED
OPY Acquisition Corp. I Warrant
OHAAW
$1.94M 0.04%
197,500

Similar funds

Radcliffe Capital Management's Q1 2022 Portfolio in Review

As of Q1 2022, Radcliffe Capital Management held 1,342 positions worth $4.4B, up 15% from $3.82B the previous quarter. Its ten largest holdings account for 15% of the portfolio.

Radcliffe Capital Management's Q1 2022 filing shows 290 new, 298 increased, 33 reduced and 125 closed positions. Its largest new stake was Zalatoris Acquisition Corp.: 1,434,939 shares worth $14M. The largest sale was Zalatoris Acquisition Corp. Units, each consisting of one share of Class A Common Stock and one-half of one redeemable public warrant, an estimated $14.5M.

By sector, the portfolio is most concentrated in Financials at 46% of assets, up from 40% a quarter earlier, followed by Healthcare and Technology.

  • Radcliffe Capital Management's largest Q1 2022 buy was Zalatoris Acquisition Corp.: 1,434,939 shares worth $14M.
  • Radcliffe Capital Management added most to Bridgetown Holdings Limited Class A Ordinary Shares in Q1 2022, an estimated $12.6M increase.
  • Radcliffe Capital Management's biggest Q1 2022 reduction was Astrea Acquisition Corp. Class A Common Stock, cutting an estimated $977K.
  • Radcliffe Capital Management fully exited Zalatoris Acquisition Corp. Units, each consisting of one share of Class A Common Stock and one-half of one redeemable public warrant in Q1 2022, selling an estimated $14.5M.
  • Radcliffe Capital Management's ten largest holdings make up 15% of its $4.4B portfolio in Q1 2022.
  • Radcliffe Capital Management opened 290 new positions and closed 125 in Q1 2022.
  • Radcliffe Capital Management's portfolio value rose 15% quarter-over-quarter to $4.4B.

Based on Radcliffe Capital Management's 13F filing for Q1 2022, filed 16 May 2022.